AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. ANIP
  4. [8-K] ANI Pharmaceuticals, Inc. Reports Material Event

[8-K] ANI Pharmaceuticals, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source:

Stock ANIP logo
Ani Pharmaceutic

NASDAQ:ANIP

ANIP Rankings

#3265 Ranked by Market Cap
N/A Ranked by Dividends
#43 Top Gainer

ANIP Latest News

Aug 8, 2025
ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance
Aug 1, 2025
ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET
Jul 23, 2025
ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIEN庐 for Use in Patients with Diabetic Macular Edema (DME)
Jul 2, 2025
ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th
Jun 12, 2025
ANI Pharmaceuticals Announces Presentation of New Preclinical Data

ANIP Latest SEC Filings

Aug 8, 2025
[10-Q] ANI Pharmaceuticals, Inc. Quarterly Earnings Report
Aug 8, 2025
[8-K] ANI Pharmaceuticals, Inc. Reports Material Event
Jul 29, 2025
[8-K] ANI Pharmaceuticals, Inc. Reports Material Event
Jul 23, 2025
[8-K] ANI Pharmaceuticals, Inc. Reports Material Event
Jul 21, 2025
[Form 4] ANI Pharmaceuticals, Inc. Insider Trading Activity

ANIP Stock Data

1.43B
18.03M
11.08%
101%
9.82%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
United States
BAUDETTE